Direct from Ann...
As in the paediatric study, the performance of the algorithm was evaluated using the method of leave-one-out cross-validation against the clinical diagnosis provided by the JHC clinical team. This diagnosis was based on the clinical presentations, auscultation findings (listening to the internal sounds of the body using a stethoscope) and imaging as well as laboratory test results when clinically indicated for the diagnosis of a given respiratory disease.
To suggest the good doctor has tainted his own trial with a lack of scientific objectivity, by using an approved method of study?? Wow..
The double blind method was for the FDA approval process.....
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C May Study Update
Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-112
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review